<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>BioLineRx Ltd. (BLRX) - Company Filings</title>
    <link>https://www.developersdigest.tech/markets/blrx/filings</link>
    <description>Latest company filings for BioLineRx Ltd. (BLRX) - annual reports, quarterly reports, major events, and insider trades, newest first.</description>
    <language>en</language>
    <lastBuildDate>Sat, 11 Jul 2026 21:17:04 GMT</lastBuildDate>
    <atom:link href="https://www.developersdigest.tech/markets/blrx/filings/feed.xml" rel="self" type="application/rss+xml" />
    <item>
      <title><![CDATA[BLRX: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1498403/000117891326002934/zk2635421.htm</link>
      <guid isPermaLink="false">0001178913-26-002934</guid>
      <description><![CDATA[BioLineRx Ltd. filed a 6-K (6-K) on 2026-05-27.]]></description>
      <pubDate>Wed, 27 May 2026 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[BLRX: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1498403/000117891326002876/zk2635386.htm</link>
      <guid isPermaLink="false">0001178913-26-002876</guid>
      <description><![CDATA[BioLineRx Ltd. filed a 6-K (6-K) on 2026-05-22.]]></description>
      <pubDate>Fri, 22 May 2026 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[BLRX: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1498403/000117891326002789/zk2635368.htm</link>
      <guid isPermaLink="false">0001178913-26-002789</guid>
      <description><![CDATA[BioLineRx Ltd. filed a 6-K (6-K) on 2026-05-19.]]></description>
      <pubDate>Tue, 19 May 2026 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[BLRX: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1498403/000117891326002262/zk2635143.htm</link>
      <guid isPermaLink="false">0001178913-26-002262</guid>
      <description><![CDATA[BioLineRx Ltd. filed a 6-K (6-K) on 2026-04-28.]]></description>
      <pubDate>Tue, 28 Apr 2026 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[BLRX: New insider ownership (3)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1498403/000117891326002057/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001178913-26-002057</guid>
      <description><![CDATA[BioLineRx Ltd. filed a New insider ownership (3) on 2026-04-10.]]></description>
      <pubDate>Fri, 10 Apr 2026 12:00:00 GMT</pubDate>
      <category>3</category>
    </item>
    <item>
      <title><![CDATA[BLRX: New insider ownership (3)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1498403/000117891326001963/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001178913-26-001963</guid>
      <description><![CDATA[BioLineRx Ltd. filed a New insider ownership (3) on 2026-03-31.]]></description>
      <pubDate>Tue, 31 Mar 2026 12:00:00 GMT</pubDate>
      <category>3</category>
    </item>
    <item>
      <title><![CDATA[BLRX: New insider ownership (3)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1498403/000117891326001961/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001178913-26-001961</guid>
      <description><![CDATA[BioLineRx Ltd. filed a New insider ownership (3) on 2026-03-31.]]></description>
      <pubDate>Tue, 31 Mar 2026 12:00:00 GMT</pubDate>
      <category>3</category>
    </item>
    <item>
      <title><![CDATA[BLRX: New insider ownership (3)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1498403/000117891326001959/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001178913-26-001959</guid>
      <description><![CDATA[BioLineRx Ltd. filed a New insider ownership (3) on 2026-03-31.]]></description>
      <pubDate>Tue, 31 Mar 2026 12:00:00 GMT</pubDate>
      <category>3</category>
    </item>
    <item>
      <title><![CDATA[BLRX: New insider ownership (3)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1498403/000117891326001958/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001178913-26-001958</guid>
      <description><![CDATA[BioLineRx Ltd. filed a New insider ownership (3) on 2026-03-31.]]></description>
      <pubDate>Tue, 31 Mar 2026 12:00:00 GMT</pubDate>
      <category>3</category>
    </item>
    <item>
      <title><![CDATA[BLRX: New insider ownership (3)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1498403/000117891326001893/xslF345X06/zk2634969.xml</link>
      <guid isPermaLink="false">0001178913-26-001893</guid>
      <description><![CDATA[BioLineRx Ltd. filed a New insider ownership (3) on 2026-03-30.]]></description>
      <pubDate>Mon, 30 Mar 2026 12:00:00 GMT</pubDate>
      <category>3</category>
    </item>
    <item>
      <title><![CDATA[BLRX: New insider ownership (3)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1498403/000117891326001890/xslF345X06/zk2634967.xml</link>
      <guid isPermaLink="false">0001178913-26-001890</guid>
      <description><![CDATA[BioLineRx Ltd. filed a New insider ownership (3) on 2026-03-30.]]></description>
      <pubDate>Mon, 30 Mar 2026 12:00:00 GMT</pubDate>
      <category>3</category>
    </item>
    <item>
      <title><![CDATA[BLRX: 20-F/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1498403/000117891326001807/zk2634966.htm</link>
      <guid isPermaLink="false">0001178913-26-001807</guid>
      <description><![CDATA[BioLineRx Ltd. filed a 20-F/A (20-F/A) on 2026-03-27.]]></description>
      <pubDate>Fri, 27 Mar 2026 12:00:00 GMT</pubDate>
      <category>20-F/A</category>
    </item>
    <item>
      <title><![CDATA[BLRX: New insider ownership (3)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1498403/000117891326001790/xslF345X06/zk2634968.xml</link>
      <guid isPermaLink="false">0001178913-26-001790</guid>
      <description><![CDATA[BioLineRx Ltd. filed a New insider ownership (3) on 2026-03-27.]]></description>
      <pubDate>Fri, 27 Mar 2026 12:00:00 GMT</pubDate>
      <category>3</category>
    </item>
    <item>
      <title><![CDATA[BLRX: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1498403/000117891326001738/zk2634945.htm</link>
      <guid isPermaLink="false">0001178913-26-001738</guid>
      <description><![CDATA[BioLineRx Ltd. filed a 6-K (6-K) on 2026-03-26.]]></description>
      <pubDate>Thu, 26 Mar 2026 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[BLRX: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1498403/000117891326001583/zk2634888.htm</link>
      <guid isPermaLink="false">0001178913-26-001583</guid>
      <description><![CDATA[BioLineRx Ltd. filed a 6-K (6-K) on 2026-03-23.]]></description>
      <pubDate>Mon, 23 Mar 2026 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[BLRX: 20-F]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1498403/000117891326001581/zk2634707.htm</link>
      <guid isPermaLink="false">0001178913-26-001581</guid>
      <description><![CDATA[BioLineRx Ltd. filed a 20-F (20-F) on 2026-03-23.]]></description>
      <pubDate>Mon, 23 Mar 2026 12:00:00 GMT</pubDate>
      <category>20-F</category>
    </item>
    <item>
      <title><![CDATA[BLRX: New insider ownership (3)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1498403/000117891326001485/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001178913-26-001485</guid>
      <description><![CDATA[BioLineRx Ltd. filed a New insider ownership (3) on 2026-03-18.]]></description>
      <pubDate>Wed, 18 Mar 2026 12:00:00 GMT</pubDate>
      <category>3</category>
    </item>
    <item>
      <title><![CDATA[BLRX: New insider ownership (3)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1498403/000117891326001479/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001178913-26-001479</guid>
      <description><![CDATA[BioLineRx Ltd. filed a New insider ownership (3) on 2026-03-18.]]></description>
      <pubDate>Wed, 18 Mar 2026 12:00:00 GMT</pubDate>
      <category>3</category>
    </item>
    <item>
      <title><![CDATA[BLRX: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1498403/000117891326000589/zk2634422.htm</link>
      <guid isPermaLink="false">0001178913-26-000589</guid>
      <description><![CDATA[BioLineRx Ltd. filed a 6-K (6-K) on 2026-02-23.]]></description>
      <pubDate>Mon, 23 Feb 2026 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[BLRX: Employee stock plan (S-8)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1498403/000117891326000208/zk2634171.htm</link>
      <guid isPermaLink="false">0001178913-26-000208</guid>
      <description><![CDATA[BioLineRx Ltd. filed a Employee stock plan (S-8) on 2026-01-23.]]></description>
      <pubDate>Fri, 23 Jan 2026 12:00:00 GMT</pubDate>
      <category>S-8</category>
    </item>
    <item>
      <title><![CDATA[BLRX: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1498403/000117891325003941/zk2534058.htm</link>
      <guid isPermaLink="false">0001178913-25-003941</guid>
      <description><![CDATA[BioLineRx Ltd. filed a 6-K (6-K) on 2025-11-24.]]></description>
      <pubDate>Mon, 24 Nov 2025 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[BLRX: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1498403/000117891325003874/zk2534026.htm</link>
      <guid isPermaLink="false">0001178913-25-003874</guid>
      <description><![CDATA[BioLineRx Ltd. filed a 6-K (6-K) on 2025-11-17.]]></description>
      <pubDate>Mon, 17 Nov 2025 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[BLRX: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1498403/000117891325003403/zk2533810.htm</link>
      <guid isPermaLink="false">0001178913-25-003403</guid>
      <description><![CDATA[BioLineRx Ltd. filed a 6-K (6-K) on 2025-09-29.]]></description>
      <pubDate>Mon, 29 Sep 2025 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[BLRX: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1498403/000117891325002883/zk2533581.htm</link>
      <guid isPermaLink="false">0001178913-25-002883</guid>
      <description><![CDATA[BioLineRx Ltd. filed a 6-K (6-K) on 2025-08-14.]]></description>
      <pubDate>Thu, 14 Aug 2025 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[BLRX: SCHEDULE 13G]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1498403/000090266425003619/xslSCHEDULE_13G_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0000902664-25-003619</guid>
      <description><![CDATA[BioLineRx Ltd. filed a SCHEDULE 13G (SCHEDULE 13G) on 2025-08-14.]]></description>
      <pubDate>Thu, 14 Aug 2025 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G</category>
    </item>
    <item>
      <title><![CDATA[BLRX: Prospectus supplement (424B5)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1498403/000117891325002463/zk2533477.htm</link>
      <guid isPermaLink="false">0001178913-25-002463</guid>
      <description><![CDATA[BioLineRx Ltd. filed a Prospectus supplement (424B5) on 2025-07-25.]]></description>
      <pubDate>Fri, 25 Jul 2025 12:00:00 GMT</pubDate>
      <category>424B5</category>
    </item>
    <item>
      <title><![CDATA[BLRX: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1498403/000117891325002266/zk2533386.htm</link>
      <guid isPermaLink="false">0001178913-25-002266</guid>
      <description><![CDATA[BioLineRx Ltd. filed a 6-K (6-K) on 2025-06-30.]]></description>
      <pubDate>Mon, 30 Jun 2025 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[BLRX: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1498403/000117891325002019/zk2533302.htm</link>
      <guid isPermaLink="false">0001178913-25-002019</guid>
      <description><![CDATA[BioLineRx Ltd. filed a 6-K (6-K) on 2025-05-30.]]></description>
      <pubDate>Fri, 30 May 2025 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[BLRX: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1498403/000117891325001952/zk2533265.htm</link>
      <guid isPermaLink="false">0001178913-25-001952</guid>
      <description><![CDATA[BioLineRx Ltd. filed a 6-K (6-K) on 2025-05-27.]]></description>
      <pubDate>Tue, 27 May 2025 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[BLRX: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1498403/000117891325001939/zk2533250.htm</link>
      <guid isPermaLink="false">0001178913-25-001939</guid>
      <description><![CDATA[BioLineRx Ltd. filed a 6-K (6-K) on 2025-05-23.]]></description>
      <pubDate>Fri, 23 May 2025 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[BLRX: Prospectus supplement (424B5)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1498403/000117891325001282/zk2532998.htm</link>
      <guid isPermaLink="false">0001178913-25-001282</guid>
      <description><![CDATA[BioLineRx Ltd. filed a Prospectus supplement (424B5) on 2025-04-11.]]></description>
      <pubDate>Fri, 11 Apr 2025 12:00:00 GMT</pubDate>
      <category>424B5</category>
    </item>
    <item>
      <title><![CDATA[BLRX: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1498403/000117891325001124/zk2532945.htm</link>
      <guid isPermaLink="false">0001178913-25-001124</guid>
      <description><![CDATA[BioLineRx Ltd. filed a 6-K (6-K) on 2025-03-31.]]></description>
      <pubDate>Mon, 31 Mar 2025 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[BLRX: 20-F]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1498403/000117891325001123/zk2532907.htm</link>
      <guid isPermaLink="false">0001178913-25-001123</guid>
      <description><![CDATA[BioLineRx Ltd. filed a 20-F (20-F) on 2025-03-31.]]></description>
      <pubDate>Mon, 31 Mar 2025 12:00:00 GMT</pubDate>
      <category>20-F</category>
    </item>
    <item>
      <title><![CDATA[BLRX: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1498403/000117891325000177/zk2532585.htm</link>
      <guid isPermaLink="false">0001178913-25-000177</guid>
      <description><![CDATA[BioLineRx Ltd. filed a 6-K (6-K) on 2025-01-21.]]></description>
      <pubDate>Tue, 21 Jan 2025 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[BLRX: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1498403/000117891325000145/zk2532569.htm</link>
      <guid isPermaLink="false">0001178913-25-000145</guid>
      <description><![CDATA[BioLineRx Ltd. filed a 6-K (6-K) on 2025-01-17.]]></description>
      <pubDate>Fri, 17 Jan 2025 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[BLRX: SCHEDULE 13G]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1498403/000121390025002765/xslSCHEDULE_13G_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001213900-25-002765</guid>
      <description><![CDATA[BioLineRx Ltd. filed a SCHEDULE 13G (SCHEDULE 13G) on 2025-01-10.]]></description>
      <pubDate>Fri, 10 Jan 2025 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G</category>
    </item>
    <item>
      <title><![CDATA[BLRX: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1498403/000117891325000047/zk2532514.htm</link>
      <guid isPermaLink="false">0001178913-25-000047</guid>
      <description><![CDATA[BioLineRx Ltd. filed a 6-K (6-K) on 2025-01-07.]]></description>
      <pubDate>Tue, 07 Jan 2025 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[BLRX: Prospectus supplement (424B5)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1498403/000117891325000045/zk2532521.htm</link>
      <guid isPermaLink="false">0001178913-25-000045</guid>
      <description><![CDATA[BioLineRx Ltd. filed a Prospectus supplement (424B5) on 2025-01-07.]]></description>
      <pubDate>Tue, 07 Jan 2025 12:00:00 GMT</pubDate>
      <category>424B5</category>
    </item>
    <item>
      <title><![CDATA[BLRX: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1498403/000117891325000026/zk2532512.htm</link>
      <guid isPermaLink="false">0001178913-25-000026</guid>
      <description><![CDATA[BioLineRx Ltd. filed a 6-K (6-K) on 2025-01-06.]]></description>
      <pubDate>Mon, 06 Jan 2025 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[BLRX: Employee stock plan (S-8)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1498403/000117891324004060/zk2432491.htm</link>
      <guid isPermaLink="false">0001178913-24-004060</guid>
      <description><![CDATA[BioLineRx Ltd. filed a Employee stock plan (S-8) on 2024-12-27.]]></description>
      <pubDate>Fri, 27 Dec 2024 12:00:00 GMT</pubDate>
      <category>S-8</category>
    </item>
    <item>
      <title><![CDATA[BLRX: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1498403/000117891324003823/zk2432387.htm</link>
      <guid isPermaLink="false">0001178913-24-003823</guid>
      <description><![CDATA[BioLineRx Ltd. filed a 6-K (6-K) on 2024-11-25.]]></description>
      <pubDate>Mon, 25 Nov 2024 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[BLRX: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1498403/000117891324003792/zk2432369.htm</link>
      <guid isPermaLink="false">0001178913-24-003792</guid>
      <description><![CDATA[BioLineRx Ltd. filed a 6-K (6-K) on 2024-11-21.]]></description>
      <pubDate>Thu, 21 Nov 2024 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[BLRX: Prospectus supplement (424B5)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1498403/000117891324003790/zk2432371.htm</link>
      <guid isPermaLink="false">0001178913-24-003790</guid>
      <description><![CDATA[BioLineRx Ltd. filed a Prospectus supplement (424B5) on 2024-11-21.]]></description>
      <pubDate>Thu, 21 Nov 2024 12:00:00 GMT</pubDate>
      <category>424B5</category>
    </item>
    <item>
      <title><![CDATA[BLRX: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1498403/000117891324003621/zk2432295.htm</link>
      <guid isPermaLink="false">0001178913-24-003621</guid>
      <description><![CDATA[BioLineRx Ltd. filed a 6-K (6-K) on 2024-11-12.]]></description>
      <pubDate>Tue, 12 Nov 2024 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[BLRX: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1498403/000117891324003475/zk2432221.htm</link>
      <guid isPermaLink="false">0001178913-24-003475</guid>
      <description><![CDATA[BioLineRx Ltd. filed a 6-K (6-K) on 2024-11-05.]]></description>
      <pubDate>Tue, 05 Nov 2024 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[BLRX: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1498403/000117891324003317/zk2432149.htm</link>
      <guid isPermaLink="false">0001178913-24-003317</guid>
      <description><![CDATA[BioLineRx Ltd. filed a 6-K (6-K) on 2024-10-16.]]></description>
      <pubDate>Wed, 16 Oct 2024 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[BLRX: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1498403/000117891324003201/zk2432094.htm</link>
      <guid isPermaLink="false">0001178913-24-003201</guid>
      <description><![CDATA[BioLineRx Ltd. filed a 6-K (6-K) on 2024-10-01.]]></description>
      <pubDate>Tue, 01 Oct 2024 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[BLRX: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1498403/000117891324002689/zk2431874.htm</link>
      <guid isPermaLink="false">0001178913-24-002689</guid>
      <description><![CDATA[BioLineRx Ltd. filed a 6-K (6-K) on 2024-08-19.]]></description>
      <pubDate>Mon, 19 Aug 2024 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[BLRX: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1498403/000117891324002633/zk2431827.htm</link>
      <guid isPermaLink="false">0001178913-24-002633</guid>
      <description><![CDATA[BioLineRx Ltd. filed a 6-K (6-K) on 2024-08-15.]]></description>
      <pubDate>Thu, 15 Aug 2024 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[BLRX: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1498403/000117891324002001/zk2431592.htm</link>
      <guid isPermaLink="false">0001178913-24-002001</guid>
      <description><![CDATA[BioLineRx Ltd. filed a 6-K (6-K) on 2024-06-18.]]></description>
      <pubDate>Tue, 18 Jun 2024 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
  </channel>
</rss>